Delivery Order SPE2DB22D2214-SPE2DB25FS4GS

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,357.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567089846 ! SUCRALFATE 1 GM/10 ML SUSP UD 10ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $35,500.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564543467 - SUCRALFATE 1 GM TABLET 90S, a pharmaceutical product. This is a firm fixed-price Delivery Order contract with a completion date of May 9, 2024. The contract was not set aside for any specific business category. In addition to this Delivery Order,...
This federal contract award, identified as SPE2DB20D3104|SPE2DB24FV8Q6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $1,347.42, is for the supply of 4565362880 - SUCRALFATE 1 GM/10 ML SUSP 420ML. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. AmerisourceBergen Drug Corp, a for-profit organization,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,361.04 firm-fixed-price delivery order is for the supply of 4,563,652,923 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has a completion date of February 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,239.18 firm fixed-price delivery order is for the supply of 4,560,242,783 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,604.04, is a delivery order for the supply of Sucralfate 1 GM/10 ML Suspension for a period ending on December 31, 2024. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not reference...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,246.16 firm fixed-price delivery order is for the supply of 420 milliliters of Sucralfate 1 gram per 10 milliliters suspension to support federal healthcare programs. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Sucralfate 1 GM/10 ML suspension medication in 420 ML bottles to the Defense Logistics Agency (DLA). The contract, valued at $1,012.97, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle...
This federal contract award, valued at $1,728.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,215.64 firm fixed-price delivery order contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition....
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS4GS
    Delivery Order

This federal contract award, valued at $2,075.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of SUCRALFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product.

The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 6/19/25, 10:01 AM